Difference between revisions of "Small cell carcinoma of the lung"

Jump to navigation Jump to search
Line 115: Line 115:
! IHC grouping
! IHC grouping
! Prevalence
! Prevalence
! Other IHC
! Notes
! Notes
! Other IHC
|-
|-
|ASCL1+ / NeuroD1-
|ASCL1+ / NeuroD1-
|41%
|41%
|TTF1+
|
|
|TTF1+
|-
|-
|ASCL1+ / NeuroD1+
|ASCL1+ / NeuroD1+
|37%
|37%
|TTF1+
|
|
|TTF1+
|-
|-
|ASCL1- / NeuroD1+
|ASCL1- / NeuroD1+
|8%
|8%
|TTF1+
|
|
|TTF1+
|-
|-
|ASCL1- / NeuroD1-
|ASCL1- / NeuroD1-
|14%
|14%
|TTF1-
|includes all POU2F3 cases which are ~9% of small cell carcinoma
|includes all POU2F3 cases which are ~9% of small cell carcinoma
|TTF1-
|}
|}


49,260

edits

Navigation menu